Tramadol abuse in a binge pattern in a young depressed woman

European Addiction Research

Volumn 20, Issue 2, 2014, Pages 82-86

  Ferrari, Anna ^a   Tiraferri, Ilaria ^a   Palazzoli, Federica ^b   Licata, Manuela ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Binge; Depression; Pain; Stimulant; Substance related disorders; Tramadol; Withdrawal

Indexed keywords

CITALOPRAM; DIAZEPAM; PROKINETIC AGENT; SPASMOLYTIC AGENT; TRAMADOL;

ABDOMINAL PAIN; ADULT; AGITATION; ANXIETY; ARTICLE; ASTHENIA; CASE REPORT; CONSTIPATION; DEPRESSION; DRUG BLOOD LEVEL; DRUG DETOXIFICATION; EUPHORIA; FATIGUE; FEMALE; FLUSHING; HEADACHE; HUMAN; INSOMNIA; LOSS OF APPETITE; NARCOTIC DEPENDENCE; NAUSEA; NERVOUSNESS; NONHODGKIN LYMPHOMA; PARESTHESIA; PRIORITY JOURNAL; PSYCHOTHERAPY; SWEATING; TACHYCARDIA; TREMOR; WITHDRAWAL SYNDROME; ZUNG SELF RATING DEPRESSION SCALE; AUTOTRANSPLANTATION; CANCER CHEMOTHERAPY; DRUG ABUSE; DRUG DOSE REDUCTION; ELECTROCARDIOGRAM; FOLLOW UP; HEALTH; HOSPITALIZATION; MONOAMINERGIC SYSTEM; NEUROLOGIC EXAMINATION; PRESCRIPTION; URINE RETENTION;

ADULT; ANALGESICS, OPIOID; DEPRESSION; FEMALE; HUMANS; OPIOID-RELATED DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME; TRAMADOL;

EID: 84896125052     PISSN: 10226877     EISSN: 14219891     Source Type: Journal    
DOI: 10.1159/000353971     Document Type: Article

References (41)

1. Barkin RL: Extended-release tramadol (Ultram ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain. Am J Ther 2008; 15: 157-166. (Pubitemid 351450780)
2. Desmeules JA: A risk-benefit assessment of tramadol in the management of pain. Eur J Pain 2000; 4(suppl A):15-21.
3. Epstein DH, Preston KL, Jasinski DR: Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol. Biol Psychol 2006; 73: 90-99.
4. Raffa RB: Basic pharmacology relevant to drug abuse assessment: tramadol as example. J Clin Pharm Ther 2008; 33: 101-108. (Pubitemid 351341408)
5. Ward AS, Haney M, Fischman MW, Foltin RW: Binge cocaine self-administration in humans: intravenous cocaine. Psychopharmacology (Berl) 1997; 132: 375-381. (Pubitemid 27373479)
6. Cho AK, Melega WP: Patterns of methamphetamine abuse and their consequences. J Addict Dis 2002; 21: 21-34. (Pubitemid 35203851)
7. Zung WWK: A rating instrument for anxiety disorders. Psychosomatics 1971; 12: 371-379.
8. Zung WWK: A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 63-70.
9. Grond S, Sablotzki A: Clinical pharmacology of tramadol. Clin Pharmacokinet 2004; 43: 879-923. (Pubitemid 39447033)
10. Driessen B, Reimann W: Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br J Pharmacol 1992; 105: 147-151.
11. Desmeules JA, Piguet V, Collart L, Dayer P: Contribution of monoaminergic modulation to the analgesic effect of tramadol. Br J Clin Pharmacol 1996; 41: 7-12. (Pubitemid 26009905)
12. Valle M, Garrido MJ, Pavon JM, Calvo R, Troconiz IF: Pharmacokinetic- pharmacodynamic modeling of the antinociceptive effects of main active metabolites of tramadol, (+)-Odesmethyltramadol and (-)-O-desmethyltramadol, in rats. J Pharmacol Exp Ther 2000; 293: 646-653. (Pubitemid 30244119)
13. Gillen C, Haurand M, Kobelt DJ, Wnendt S: Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor. Naunyn Schmiedebergs Arch Pharmacol 2000; 362: 116-121. (Pubitemid 30640039)
14. Frink MC, Hennies HH, Englberger W, Haurand M, Wilffert B: Influence of tramadol on neurotransmitter systems of the rat brain. Arzneimittelforschung 1996; 46: 1029-1036. (Pubitemid 26391736)
15. Rojas-Corrales MO, Berrocoso E, Gibert-Rahola J, Micó JA: Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats. Life Sci 2002; 72: 143-152. (Pubitemid 35363284)
16. Yalcin I, Aksu F, Bodard S, Chalon S, Belzung C: Antidepressant-like effect of tramadol in the unpredictable chronic mild stress procedure: possible involvement of the noradrenergic system. Behav Pharmacol 2007; 18: 623-631. (Pubitemid 47524888)
17. Barber J: Examining the use of tramadol hydrochloride as an antidepressant. Exp Clin Psychopharmacol 2011; 19: 123-130.
18. Lofwall MR, Walsh SL, Bigelow GE, Strain EC: Modest opioid withdrawal suppression efficacy of oral tramadol in humans. Psychopharmacology (Berl) 2007; 194: 381-393. (Pubitemid 47389347)
19. Duke AN, Bigelow GE, Lanier RK, Strain EC: Discriminative stimulus effects of tramadol in humans. J Pharmacol Exp Ther 2011; 338: 255-262.
20. Stoops WW, Lofwall MR, Nuzzo PA, Craig LB, Siegel AJ, Walsh SL: Pharmacodynamic profile of tramadol in humans: influence of naltrexone pretreatment. Psychopharmacology (Berl) 2012; 223: 427-438.
21. Senay EC, Adams EH, Geller A, Inciardi JA, Muñoz A, Schnoll SH, Woody GE, Cicero TJ: Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend 2003; 69: 233-241. (Pubitemid 36293935)
22. Taghaddosinejad F, Mehrpour O, Afshari R, Seghatoleslami A, Abdollahi M, Dart RC: Factors related to seizure in tramadol poisoning and its blood concentration. J Med Toxicol 2011; 7: 183-188.
23. Nelson EM, Philbrick AM: Avoiding serotonin syndrome: the nature of the interaction between tramadol and selective serotonin reuptake inhibitors. Ann Pharmacother 2012; 46: 1712-1716.
24. Jeppesen U, Gram LF, Vistisen K, Loft S, Poulsen HE, Brøsen K: Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine. Eur J Clin Pharmacol 1996; 51: 73-78. (Pubitemid 26300937)
25. Paar WD, Poche S, Gerloff J, Dengler HJ: Polymorphic CYP2D6 mediates O-demethylation of the opioid analgesic tramadol. Eur J Clin Pharmacol 1997; 53: 235-239. (Pubitemid 28018297)
26. Rouini MR, Ardakani YH, Soltani F, Aboul-Enein HY, Foroumadi A: Development and validation of a rapid HPLC method for simultaneous determination of tramadol, and its two main metabolites in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 830: 207-211. (Pubitemid 43075452)
27. Ehrenreich H, Poser W: Dependence on tram adol. Clin Investig 1993; 72: 76.
28. Rodriguez Villamañan JC, Albaladejo Blanco C, Sanchez Sanchez A, Carvajal A, Martin Arias L, Garcia del Pozo J: Withdrawal syndrome after long-term treatment with tramadol. Br J Gen Pract 2000; 50: 406. (Pubitemid 30245629)
29. Freye E, Levy J: Acute abstinence syndrome following abrupt cessation of long-term use of tramadol (Ultram): a case study. Eur J Pain 2000; 4: 307-311.
30. Thomas AN, Suresh M: Opiate withdrawal after tramadol and patient-controlled analgesia. Anaesthesia 2000; 55: 826-827. (Pubitemid 30628007)
31. Yates WR, Nguyen MH, Warnock JK: Tramadol dependence with no history of substance abuse. Am J Psychiatry 2001; 158: 964. (Pubitemid 32547634)
32. Barsotti CE, Mycyk MB, Reyes J: Withdrawal syndrome from tramadol hydrochloride. Am J Emerg Med 2003; 21: 87-88.
33. Soyka M, Backmund M, Hasemann S: Tramadol use and dependence in chronic noncancer pain patients. Pharmacopsychiatry 2004; 37: 191-192. (Pubitemid 38916430)
34. Pollice R, Casacchia M, Bianchini V, Mazza M, Conti CM, Roncone R: Severe tramadol addiction in a 61 year-old woman without a history of substance abuse. Int J Immunopathol Pharmacol 2008; 21: 475-476. (Pubitemid 351988415)
35. Stoehr JD, Essary AC, Ou C, Ashby R, Sucher M: The risk of tramadol abuse and dependence: findings in two patients. JAAPA 2009; 22: 31-32, 34-35.
36. Tjäderborn M, Jönsson AK, Ahlner J, Hägg S: Tramadol dependence: a survey of spontaneously reported cases in Sweden. Pharmacoepidemiol Drug Saf 2009; 18: 1192-1198.
37. Reeves RR, Cox SK: Similar effects of tramadol and venlafaxine in major depressive disorder. South Med J 2008; 101: 193-195.
38. Tao Q, Stone DJ, Borenstein MR, Codd EE, Coogan TP, Desai-Krieger D, Liao S, Raffa RB: Differential tramadol and O-desmethyl metabolite levels in brain vs plasma of mice and rats administered tramadol hydrochloride orally. J Clin Pharm Ther 2002; 27: 99-106. (Pubitemid 34451202)
39. Means-Christensen AJ, Roy-Byrne PP, Sherbourne CD, Craske MG, Stein MB: Relationships among pain, anxiety, and depression in primary care. Depress Anxiety 2008; 25: 593-600.
40. Babalonis S, Lofwall MR, Nuzzo PA, Siegel AJ, Walsh SL: Abuse liability and reinforcing efficacy of oral tramadol in humans. Drug Alcohol Depend 2013; 129: 116-122.
41. Raffa RB, Buschmann H, Christoph T, Eichenbaum G, Englberger W, Flores CM, Hertrampf T, Kögel B, Schiene K, Strassburger W, Terlinden R, Tzschentke TM: Mechanistic and functional differentiation of tapentadol and tramadol. Expert Opin Pharmacother 2012; 13: 1437-1449.